Schedule 13G ownership disclosure
Fulcrum Therapeutics Inc
Security class unavailable · CUSIP: 359616109
Event date: 2020-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-037751
- Form type
- SC 13G
- Filer
- Revolution Medicines, Inc.
- CIK
- CIK 1628171
- Filed
- Feb 11, 2021
- Reporting period
- Feb 13, 2020
- Description
- Schedule 13G beneficial ownership